ATE130304T1 - Neue alpha-glukosidaseinhibitoren. - Google Patents

Neue alpha-glukosidaseinhibitoren.

Info

Publication number
ATE130304T1
ATE130304T1 AT91912140T AT91912140T ATE130304T1 AT E130304 T1 ATE130304 T1 AT E130304T1 AT 91912140 T AT91912140 T AT 91912140T AT 91912140 T AT91912140 T AT 91912140T AT E130304 T1 ATE130304 T1 AT E130304T1
Authority
AT
Austria
Prior art keywords
glucosidasine
inhibitors
new alpha
alpha
new
Prior art date
Application number
AT91912140T
Other languages
English (en)
Inventor
Jean-Bernard Ducep
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE130304T1 publication Critical patent/ATE130304T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
AT91912140T 1990-06-08 1991-05-17 Neue alpha-glukosidaseinhibitoren. ATE130304T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401582 1990-06-08

Publications (1)

Publication Number Publication Date
ATE130304T1 true ATE130304T1 (de) 1995-12-15

Family

ID=8205720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912140T ATE130304T1 (de) 1990-06-08 1991-05-17 Neue alpha-glukosidaseinhibitoren.

Country Status (7)

Country Link
EP (1) EP0532668B1 (de)
JP (1) JP3136491B2 (de)
AT (1) ATE130304T1 (de)
AU (1) AU8069891A (de)
DE (1) DE69114707T2 (de)
ES (1) ES2082212T3 (de)
WO (1) WO1991018915A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
AU7083594A (en) * 1993-07-02 1995-01-24 Nippon Shinyaku Co. Ltd. Galactosylmoranoline derivative
AU7467394A (en) * 1993-08-23 1995-03-21 Nippon Shinyaku Co. Ltd. Galactosylmoranoline derivative
US5633233A (en) * 1995-06-07 1997-05-27 Alberta Research Council Modified kojibiosides analogues
WO2005092334A2 (en) * 2004-03-25 2005-10-06 David Priestman Use of n-substituted imino sugars for appetite suppression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055078B2 (ja) * 1980-12-01 1985-12-03 日本新薬株式会社 モラノリンの誘導体
GB2181729B (en) * 1985-10-12 1990-04-04 Nippon Shinyaku Co Ltd Glucosylmoranoline derivatives and production thereof
JPS62242692A (ja) * 1986-04-15 1987-10-23 Nippon Shinyaku Co Ltd モラノリン誘導体の製造法
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体

Also Published As

Publication number Publication date
EP0532668B1 (de) 1995-11-15
JPH05509082A (ja) 1993-12-16
JP3136491B2 (ja) 2001-02-19
EP0532668A1 (de) 1993-03-24
WO1991018915A1 (en) 1991-12-12
DE69114707T2 (de) 1996-06-13
AU8069891A (en) 1991-12-31
ES2082212T3 (es) 1996-03-16
DE69114707D1 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
DK0791571T3 (da) Benzoylderivater
DK162770C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-heteroaromatiske carboxylater
DK15589A (da) Kemiske forbindelser
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
DE68918217D1 (de) Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs.
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
DE69113221T2 (de) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
DE69010294T2 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0522001T3 (da) Understøttende anvendelse af Linomide
DE59008844D1 (de) Benzylselenobenzamide von Aminopyridinen und Picolylaminen.
ES2085937T3 (es) Desacilacion enzimatica de acil-aminosorbosas y su uso en la fabricacion de 1-desoxinoyirimicina.
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time